Table 2 WT GIST patients
Patient | KIT mutation | PDGFR mutation | BRAF mutation | SDHB expression | Duration on regorafenib (months) | Best response to regorafenib as per RECIST 1.1 | Reason for discontinuing regorafenib |
|---|---|---|---|---|---|---|---|
1 | No | No | No | Normal | 3.6 | PR | Toxicity |
2 | No | No | Unknown | Unknown | 18.3 | SD | PD |
3 | No | No | Unknown | Unknown | 2.9 | SD | PD |
4 | No | No | No | Normal | 6.7 | SD | PD |